Navigation Links
diaDexus Preannounces Strong Second Quarter Revenues
Date:6/29/2011

on current expectations and assumptions, and entail various known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Important factors known to diaDexus that could cause actual results to differ materially from those expressed in such forward-looking statements include diaDexus' ability to reintroduce its PLAC TIA product, shipments of which were suspended in May 2010; diaDexus' ability to successfully commercialize the automated Lp-PLA2 assay; diaDexus' ability to demonstrate that treatment of individuals based on their Lp-PLA2 levels improves clinical outcomes in prospective clinical studies; the rate of adoption of the PLAC Test by doctors and laboratories; the insurance payer community's acceptance of and reimbursement for the PLAC Test; diaDexus' reliance on sole source third party manufacturers to manufacture and supply its main reagent and the PLAC Test; its ability to retain key employees and to attract, retain and motivate other qualified personnel; diaDexus' limited revenue and cash resources; diaDexus' ability to accurately forecast revenues prior to review and issuance of its financial statements for the period ended June 30, 2011; and diaDexus' significant corporate expenses, including expenses associated with being a public company. Additional factors that could cause diaDexus' results to differ materially from those described in the forward-looking statements can be found in diaDexus' most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q and other reports filed with the Securities and Exchange Commission, and available at the SEC's web site at www.sec.gov. The information set forth herein speaks only as of the date hereof, and diaDexus disclaims any intention and does not assume any obligation to update or revise any forward looking statement, whether as a result of new information, future even
'/>"/>
SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. VaxGen and diaDexus Complete Merger
2. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
3. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
4. diaDexus to Present at the Canaccord Genuity Healthcare Conference
5. diaDexus Announces FDA Clearance for New Automated PLAC Test
6. diaDexus, Inc. Reports 2011 First Quarter Financial Results
7. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
8. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
9. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
10. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
11. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015   InspireMD, Inc. (NYSE MKT: ... protection systems ("EPS"), today announced that its CGuard TM ... principle investigator Prof. Piotr Musialek , at the ... Paris, France . PARADIGM, an investigator-initiated ... c A roti D revascularization I n symptomatic ...
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... Soligenix, Inc. (Soligenix or the Company) (OTC Bulletin ... today announced that it has entered into a definitive ... novel technology for use in the development of subunit ...  The technology is the subject of several United States ...
... PARSIPPANY, N.J., Jan. 27, 2011 Significant flooding occurred ... and early January 2011.  Thousands of residents were affected. ... was launched on 29 December 2010, by Premier of ... who pitched in to help their fellow citizens clean-up ...
Cached Medicine Technology:Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology 2Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology 3Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology 4DSM Joins International Response to Flooding in Australia 2DSM Joins International Response to Flooding in Australia 3
(Date:5/22/2015)... May 22, 2015 Medivo, Inc., a leader ... Rates and Genotype Results in ‘Baby Boomers’ Screened for HCV ... Nationwide Lab Test Database” at Digestive Disease Week, May 16-19, ... Affairs and Analytics team members Carol Smyth, MB; Jason Bhan, ... Parker, MSI, along with Nancy Reau, MD from the University ...
(Date:5/22/2015)... May 22, 2015 Wimbledon Health Partners, ... electrocardiogram (EKG), echocardiogram and NCV testing , is ... highly respected All American National athlete, to the Wimbledon ... find the high level of testing and information it ... and their athletic trainers, this way they can focus ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
(Date:5/22/2015)... 2015 Co founders Greenlee and James Chapko, ... general dentists to immediately deliver fully integrated dental implant services ... of the medical surgeon. , The Center, whose name ... general dentists from placing dental implants. These 6 roadblocks ... introduce the surgical placement of dental implants into his or ...
(Date:5/22/2015)... Maine (PRWEB) May 22, 2015 ... single-use swabs for the medical, diagnostic, environmental, and ... entire line of products in the US. At ... their operations outside the US, Puritan remains committed ... products at their Guilford, Maine facility. , Since ...
Breaking Medicine News(10 mins):Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... now have many more treatment options than in the ... derived by modifying substances found in humans or animals, ... the symptoms. The cost of biologic DMARDs is a ... 100 times more than a year,s supply of older, ...
... million people in America,have some form of epilepsy, a ... Treatment can be tough to get, though, for people,without ... This National Epilepsy Awareness Month, Pfizer wants to tell,you ... and women get,prescription medicines for free or at a ...
... Study finds twice the incidence of ,food insecurity, , , TUESDAY, ... smokers are more likely to be underfed and undernourished, a ... members of smoking households, but children feel the impact the ... at New York University School of Medicine. , "We know ...
... BlueCross announced the,launch of the only Blue branded dental ... Dental. No specific date was set for the,rollout of ... be available to,customers in 2009., "We believe that ... in our region because it carries the promise of ...
... DIEGO, Nov. 4 Accumetrics, Inc. announces the,appointment of ... of Operations and R&D. Mr. Dippel will oversee the ... are excited to have Bill join our team," said ... 33 years of,operations and R&D experience in the healthcare ...
... The American Society of,Hematology (ASH), the world,s largest ... to its Executive Committee, the,governing body of the ... January 2009., J. Evan Sadler, MD, PhD, ... by successive terms as president-elect and president. Charles,Abrams, ...
Cached Medicine News:Health News:Medicaid policies vary widely for rheumatoid arthritis drugs 2Health News:Smokers' Homes More Likely to House Hungry Kids 2Health News:Smokers' Homes More Likely to House Hungry Kids 3Health News:Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D 2Health News:New Leadership Elected to the American Society of Hematology 2
Male Support Brief...
For Lipoplasty or surgery of abdomen, flanks and midriff...
Select Support Brief...
Female High Waist Briefs...
Medicine Products: